Alnylam Pharmaceuticals (ALNY) PT Lowered to $305 at Bernstein SocGen Group
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $228.65 +0.67%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 6
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 6
Join SI Premium – FREE
Bernstein SocGen Group analyst William Pickering lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $305.00 (from $310.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $256 at Wells Fargo
- JPMorgan Upgrades Resona Holdings, Inc (8308:JP) (RSNHF) to Overweight
- Grenke AG (GLJ:GR) (GKSGF) PT Lowered to EUR23 at Berenberg
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
